1 中国疾病预防控制中心慢性非传染性疾病预防控制中心,国家卫生健康委统计信息中心.中国死因监测数据集.2020[M].北京:中国科学技术出版社,2021:27-28. 2 Han B,Zheng R,Zeng H,et al.Cancer incidence and mortality in China,2022[J].J Natl Cancer Cent,2024,4(1):47-53. 3 Bray F,Parkin DM.Evaluation of data quality in the cancer registry:principles and methods.Part I:comparability,validity and timeliness[J].Eur J Cancer,2009,45(5):747-755. 4 国家癌症中心.2022中国肿瘤登记年报[M].北京:人民卫生出版社,2025:78-83. 5 陈茂森,陈杨,石青萍,等.2020年云南省恶性肿瘤发病和死亡分析[J].实用肿瘤学杂志,2024,38(5):283-288. 6 钟女娟,马晶昱,许志达.2019年福建省福清市恶性肿瘤发病与死亡情况及2015—2019年趋势分析[J].实用肿瘤学杂志,2024,38(1):1-6. 7 Ju W,Zheng R,Zhang S,et al.Cancer statistics in Chinese older people,2022:current burden,time trends,and comparisons with the US,Japan,and the Republic of Korea[J].Sci China Life Sci,2023,66(5):1079-1091. 8 袁芝佩,王丹,成姝雯,等.2019年四川省肿瘤登记地区恶性肿瘤发病与死亡及2015—2019年变化趋势分析[J].中国肿瘤,2024,33(7):515-522. 9 Feng R,Su Q,Huang X,et al.Cancer situation in China:what does the China cancer map indicate from the first national death survey to the latest cancer registration?[J].Cancer Commun(Lond),2023,43(1):75-86. 10 Qiu H,Cao S,Xu R.Cancer incidence,mortality,and burden in China:a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020[J].Cancer Commun(Lond),2021,41(10):1037-1048. 11 陈红雨,秦明芳,杨永芳,等.云南省成年居民慢性病危险因素流行情况及聚类特征分析[J].中国慢性病预防与控制,2022,30(11):806-810. 12 刘毅,陈平,张寒蕾,等.云南省成人媒体控烟信息及烟草广告暴露状况调查[J].健康教育与健康促进,2023,18(5):454-457. 13 Cao M,Li H,Sun D,et al.Cancer screening in China:The current status,challenges,and suggestions[J].Cancer Lett,2021,506:120-127. 14 Bretthauer M,Loberg M,Wieszczy P,et al.Effect of colonoscopy screening on risks of colorectal cancer and related death[J].N Engl J Med,2022,387(17):1547-1556. 15 师金,梁迪,李道娟,等.中国城市癌症早诊早治项目筛查依从性及影响因素研究[J].中国肿瘤,2021,30(8):591-599. 16 Ilic D,Djulbegovic M,Jung JH,et al.Prostate cancer screening with prostate-specific antigen(PSA)test:a systematic review and meta-analysis[J].BMJ,2018,362:k3519. 17 李纪宾,王宝华,邹小农,等.前列腺癌的筛查策略现状及中国前列腺癌筛查专家共识[J].中国肿瘤临床与康复,2024,31(4):201-217. 18 Shaukat A,Levin TR.Current and future colorectal cancer screening strategies[J].Nat Rev Gastroenterol Hepatol,2022,19(8):521-531. 19 Chen YJ,Roumeliotis TI,Chang YH,et al.Proteogenomics of non-smoking lung cancer in East Asia delineates molecular signatures of pathogenesis and progression[J].Cell,2020,182(1):226-244. 20 Lancaster HL,Heuvelmans MA,Oudkerk M.Low-dose computed tomography lung cancer screening:clinical evidence and implementation research[J].J Intern Med,2022,292(1):68-80. |